Electrostimulation with CorTec Cuff Electrodes Inhibits New-onset Autoimmune Diabetes

Type 1 diabetes is an autoimmune disease for which no causal cure exists to date. The only treatment method available consists of closely monitoring blood sugar levels and injecting insulin several times a day. This treatment, however, does not eliminate the cause of the disease, has to be kept up for the patient’s whole life, and comes with frequent complications, as blood sugar levels can reach critical levels when insulin injections are not optimally adjusted.

A multidisciplinary international team of investigators from the University of Côte d’Azur, the Case Western University as well as from Galvani Bioelectronics has now developed an alternative treatment approach that could tackle the disease at its roots. The idea is to suppress the autoimmune process early on in the disease to save insulin-producing beta cells in the pancreas and stop the disease from progressing.

 

Instead of trying to develop a new drug to systemically inhibit the immune response, the authors applied the novel principle of bioelectronic medicine to induce pinpointed immunosuppression in the pancreas by electrically stimulating the specific nerve that controls the immune response there. This was no small feat at all. In a meticulous procedure, the responsible nerve was first identified in pre-clinical studies. In a second step . Then, they had to find a way had to be found to electrically target this nerve, which in the animal model for the disease is only 50 micrometers thick and thus thinner than a human hair. AirRay Cuff Electrodes from CorTec proved instrumental in finding a way to chronically stimulate this tiny nerve in living and mobile mice.

With this experimental setup in place, the authors were able to show that chronic electrostimulation at the identified nerve can reduce the immune response, reduce glycemia and even slow down disease progression, with minimal side effects.

 

This offers are cause for hope for patients with, type 1 diabetes and could form the basis for a first causal treatment of the disease, avoiding or delaying treatment with insulin and reducing the corresponding side-effects and risks.

 

Citation:

Mélanie Guyot, Thomas Simon, Franck Ceppo, Clara Panzolini, Alice Guyon, Julien Lavergne, Emilie Murris, Douglas Daoudlarian, Romain Brusini, Hadi Zarif, Sophie Abélanet, Sandrine Hugues-Ascery, Jean-Louis Divoux, Stephen J. Lewis, Arun Sridhar, Nicolas Glaichenhaus and Philippe Blancou: Pancreatic nerve electrostimulation inhibits recent-onset autoimmune diabetes.
Nat Biotechnol. 2019 Dec;37(12):1446-1451. doi: 10.1038/s41587-019-0295-8

 


Read more about CorTec Products for the Peripheral Nervous System

Further readings in Technology and User Stories:
No data was found

Contact

Do you have any questions regarding our Company, our Products or our Technology?
We are happy to receive your message!

Get a Quote

We’re happy to help you realize your next project. Whether it is a complete implantable system design, an electrode or another component.

Please fill out the form below and our sales team will be in contact with you shortly.

SPECIFICATIONS

FEATURE 

Recording channels 

Sampling rate 

Sampling dynamic range 

High pass filter cut-off 

Low pass filter cut-off 

Amplifier band pass gain 

Band pass roll-off 

Reference


Stimulation 

Stimulation channels 

Current 

Current source 

Pulse width 

Power supply 

Wireless data transmission 

Closed Loop latency

VALUE

32 

1 kHz 

16 bit (74 nV smallest increment) 

ca. 2 Hz 

325 Hz 

Adjustable: 100-750 

20 dB/dec 

Any (subset) of the recording channels selectable by software or one dedicated hard-wired additional contact 

Current-controlled, biphasic, rectangular, asymmetric stimulus pulses (cathodic amplitude with pulse width followed by an anodic counter pulse of 1/4x amplitude and 4x pulse width) 

 32 

Max. -6 mA / +1.5 mA (24 µA increments) within

 compliance voltage range of -11 V to +5 V 

Can be directed to any of the 32 electrode contacts 

Negative phase: 10 µs – 2,500 µs

Wireless inductive, 120-140 kHz

Bi-directional, radio frequency in 2400-2483.5 MHz band ≤ 40 ms